Atlas Trials

Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine

Clinical trial NCT02825576 · TERMINATED

Trial details

NCT number
NCT02825576
Sponsor
Northern Sydney Anaesthesia Research Institute
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Complications
Start date
2018-12-03
Primary completion
2020-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.